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White-rot fungi (WRF) mediated treatment can offer an environmentally friendly platform for the 
removal of pharmaceuticals and personal care products (PPCPs) from wastewater. These PPCPs may 
have adverse impacts on aquatic organisms and even human and thus their removal during wastewater 
treatment is of significant interest to the water industry. Whole-cell WRF or their extracellular lignin 
modifying enzymes (LMEs) have been reported to efficiently degrade PPCPs that are persistent to 
conventional activated sludge process. WRF mediated treatment of PPCPs depends on a number of 
factors including physicochemical properties of PPCPs (e.g., hydrophobicity and chemical structure) and 
wastewater matrix (e.g., pH, temperature and dissolved constituents), type of WRF species and their 
specific extracellular enzymes. This review critically analyzes the performance of whole-cell WRF and 
their LMEs for the removal of PPCPs: particularly it offers insights into PPCP removal mechanisms (e.g., 
biosorption vs. biodegradation) and degradation pathways as well as the formation of intermediate 
byproducts.  
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Trace organic contaminants (TrOCs) include diverse groups of chemicals such as pharmaceuticals and 
personal care products (PPCPs), pesticides, surfactants and industrial chemicals. Due to their ineffective 
removal by the conventional wastewater treatment processes, these TrOCs are commonly detected in the 
aquatic environment including surface water and groundwater, and even seawater [1, 2, 3]. Most TrOCs 
are biologically active even at trace concentrations (in the range of few ng/L) and can impose detrimental 
impacts on aquatic environment as well as on human health [4, 5]. For example, PPCPs such as synthetic 
hormones can induce endocrine disrupting effects in aquatic lives [6, 7]. Some of these TrOCs can also 
accumulate in aquatic biota. Exposure to a non- lethal dose of antibiotics may result in the development of 
antibiotic resistant genes in bacteria which is an emerging concern for human health according to the 
World Health Organization [8, 9, 10, 11]. Biological treatment processes are environmentally friendly and 
cost effective [12, 13, 14]. The conventional activated sludge and membrane bioreactor processes can 
efficiently remove bulk organics, nutrients and pathogens. However, certain groups of PPCPs such as 
significantly hydrophilic compounds and/or compounds with strong electron withdrawing functional 
groups are poorly removed by the conventional biological treatment processes [2, 15, 16, 17]. Thus, 
effective treatment processes to remove PPCPs from wastewater is urgently needed.  
Extracellular enzymes  of white-rot fungi (WRF) are characterized by their capacity to degrade the 
complex structure of lignin, which also enables them to degrade a wide range of resistant pollutants 
including  synthetic dyes, chlorophenols, polychlorinated biphenyls and polycyclic aromatic 
hydrocarbons [18, 19, 20, 21, 22, 23]. WRF and their lignin modifying enzymes (LMEs) have been 
investigated recently for the degradation of a broad spectrum of PPCPs [24, 25, 26, 27]. The potential of 
WRF for the removal of PPCPs has been investigated mostly in batch mode. There are only a few studies 
on continuous flow reactor configurations [24, 26, 28, 29, 30]. Despite a significant research effort, 
efficient removal of PPCPs by WRF mediated treatment, their removal mechanisms and degradation 
pathways remain largely to be elucidated. There have been a few excellent reviews on bioremediation of 
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recalcitrant compounds by WRF and their LMEs [31, 32, 33, 34, 35]. However, aspects such as 
comparative performance of different whole-cell WRF species, the impacts of different reactor 
configurations as well as the performance under non-sterile environment deserve further attention. 
Moreover, factors controlling the performance of the crude and/or purified LMEs for the degradation of 
PPCPs, particularly the redox-mediator enhanced laccase systems remain largely unaddressed. This 
critical review fills these gaps. Degradation mechanisms and pathways for the removal of PPCPs are also 
critically discussed and the major metabolites or intermediate products following WRF treatment are 
identified. In addition, the technological challenges associated with the continuous fungal bioreactors are 
discussed and possible solutions are outlined. Directions for future research are also provided. 
2. Enzymatic Systems of WRF  
Several features of WRF make their application for PPCP removal attractive: (i) the non-specificity of 
their enzyme systems, facilitating degradation of a broad spectrum of pollutants [36, 37]; (ii) the hyphal 
growth, a defining property of filamentous fungi including WRF, enabling them to access pollutants by 
colonizing fast; (iii) the secretion of extracellular enzymes enabling them to degrade pollutants with low 
water solubility; and (iv) the ability of some WRF species to degrade pollutants in nutrient deficient 
environment over a wide range of pH. Notable, however, is that resistant pollutant degradation by WRF is 
a co-metabolic process, i.e., occurs in presence of an easily degradable substrate. Since, PPCP 
degradation by WRF depends mainly on their enzyme systems, these are described in this section. 
Three different types of extracellular LME, namely, lignin peroxidases (LiPs), laccase and manganese-
dependent peroxidases (MnPs), are secreted by WRF. The main difference between laccase and 
peroxidases is the electron acceptor where oxygen and hydrogen peroxide are the respective electron 
acceptors. [38, 39]. Not every WRF species produces all three enzymes, and combination of major LME 
varies from one WRF species to another. Even the secretion pattern of enzymes varies within a WRF 
species. For instance, different strains of T. versicolor has been reported to secrete all three enzymes but 
laccase is the main enzyme secreted by the strain ATCC 7731 [40, 41, 42]. In addition, composition of 
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growth medium and culture conditions can influence the secretion of a specific enzyme. Degradation of 
some pollutants such as phenolic compounds, peptides, and organic acids by WRF may result in the 
formation of low molecular weight mediators which can enhance the spectrum of compounds degraded by 
WRF [37, 39, 43]. Based on the secretion patterns of enzymes, WRF can be categorized as [44]: (i) MnP-
laccase group such as T. versicolor, P. ostreatus, D. squalens and P. tigrinus; (ii) LiP-laccase group such 
as P. ochraceofulva; and (iii) LiP-MnP group such as P. chrysosporium. 
In addition to the extracellular enzymes, intercellular enzymes may play an important role in the 
degradation of xenobiotics. Intracellular cytochrome P450 enzyme system has been observed to play a 
vital role in the degradation of some PPCPs such as and chlorinated hydrocarbons and polycyclic 
aromatic hydrocarbons [45, 46, 47]. Cytochrome P450 is a group of monooxygenases which can degrade 
PPCPs by catalyzing a number of reactions such as heteroatom oxygenation, dehalogenation and 
hydroxylation [48].  
3. Modes of PPCP Degradation by WRF  
Different WRF and their LME have been investigated under different experimental conditions for the 
removal of PPCPs - either by whole-cell WRF culture or by using the crude and/or purified enzyme 
extracts. In this section, different modes of PPCP degradation via WRF and their LMEs are critically 
reviewed.  
3.1. Removal by Whole-cell WRF 
3.1.1. Degradation capacity of different WRF 
Although whole-cell WRF cultures, either in submerged or solid media, have been used for the removal 
of PPCPs, submerged whole-cell WRF cultures have been more commonly reported. Since WRF species 
harbor different enzyme systems, the extent of PPCP removal achieved by different WRF species also 
varies. PPCP removal performance by different WRF species is presented in Table 1. Notably, 
temperature and pH for these studies were in the range of 25-30oC and 4.5-5, respectively, with glucose 
used as the common electron donor.     
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T. versicolor, also known as Coriolus versicolor [49, 50], has been investigated in several studies for the 
removal of PPCPs both in batch and continuous reactors  [24, 26, 27, 43, 51, 52, 53]. Depending on the 
strain, T. versicolor may contain laccase, LiP and MnP, with laccase being the predominant enzyme in 
some strains. It can be observed from Table 1 that T. versicolor achieved significant removal (>70%) for 
most of the tested PPCPs. PPCPs such as steroid hormones, nonylphenol and octocrylene can induce 
endocrine disrupting effects [54, 55]. Their removal by T. versicolor in literature ranges from 80-99% 
regardless of the operating conditions. Conversely, poor and unstable removal was reported for particular 
pharmaceuticals namely ciprofloxacine (35%), salicylic acid (0-5%), azithromycin (26%), tetracyclin (0-
5%) and carbamazepine (negligible to 90%). Low and/or unstable removal of these compounds can be 
attributed to the presence of strong electron withdrawing functional groups  in their chemical structure 
[31]. Compared to the pharmaceuticals, the removal of personal care products has been communicated in 
only a limited number of studies [27, 52]. However, T. versicolor has been shown to achieve high 
removal of ingredients of personal care products such as triclosan, oxybenzone, octocrylene and 
nonylphenol (Table 1).  
[TABLE 1] 
Other WRF species such as P. chrysosporium [56, 57], B. adusta , D. squalens and P. ostreatus 
containing different combinations of LMEs have also been investigated for the removal of PPCPs (Table 
1). However, these studies reported the removal of only a few PPCPs such as ibuprofen, diclofenac and 
triclosan. Despite the difference in enzyme secretion pattern of these WRF, efficient removal (in the range 
of 70-99%) was achieved for most tested PPCPs, with uncertain/unstable removal reported for 
carbamazepine, which is a known persistent pharmaceutical. It is important to note that a direct 
comparison of PPCP removal data from different studies may not be valid due to the differences in 
operating conditions and reactor configurations as well as difference in their enzymatic systems. 




3.1.2. WRF Reactor configurations 
Different reactor configurations have been explored for the continuous treatment of PPCPs in WRF-based 
systems (Table 1). Since whole-cell WRF based treatment systems are still in their development phase, 
the reactor design and configurations are of significant importance. Hence, the salient features of the 
reactor configurations studied to date for the removal of PPCPs, namely, stirred tank bioreactors [56, 57], 
bubble column bioreactors, fluidized or packed bed bioreactors [59, 60, 61] and membrane bioreactors 
[62, 63, 64, 65] are briefly discussed here to provide a general overview.  
Among all the reactor configurations, stirred tank bioreactor has been the most common type of reactor 
used for the treatment of PPCPs in WRF based treatment systems. This reactor type has been explored 
mostly in batch and sterile modes [56, 57]. In this reactor aeration is provided usually at the bottom of the 
reactor which is dispersed via mechanical agitation. Mechanical mixing also ensures the uniform mixing 
of the growth medium and wastewater in the reactor [59]. Enhanced production of extracellular enzymes 
could be achieved in stirred tank bioreactors compared to other reactor configurations. For instance, Babič 
and Pavko [66] investigated the production of laccase and MnP from D. squalens in stirred tank 
bioreactor and bubble column reactor under different operating conditions such as incubation time and 
agitation speed: they observed that laccase production was as much as 70% higher in the former, although 
the production of MnP was comparable [66]. Agitation speed and high shear rate may influence the 
morphology of the fungal biomass. In a study by Cao et al. [67], impact of two reactor configurations, 
namely stirred tank bioreactor and airlift bioreactor, on the morphology of P. sanguineus was 
investigated. They found that the morphology of the fungal biomass was adversely impacted in the stirred 
tank bioreactor which uses strong mechanical mixing. Consistent with the finding of Cao et al. [67], it has 
been reported that excessive agitation may lead to the rupturing of fungal hyphae [59, 68, 69]. Therefore, 
agitation/mixing speed in bioreactors is an important parameter governing fungal morphology and 
enzymatic activity.   
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Fluidized bed bioreactor is another type that has been used for the removal of PPCPs from municipal and 
synthetic wastewater [24, 58]. In this type of reactor, fungal biomass rapidly moves around the solid 
carrier (‘bed’), allowing uniform mixing of the reaction mixture [70]. However, aggregation of fungal 
biomass may cause poor fluidization, resulting in spouting of bed. Biomass aggregation can be avoided 
by intermittent and partial purging of the biomass [71].  
A bubble column reactor coupled with a microfiltration membrane has been recently explored for the 
removal of PPCPs [26, 27]. Such fungal membrane bioreactor was expected to offer some additional 
advantages over bubble column reactors [14, 72, 73] such as: (i) formation of biofilm on the membrane 
surface that may enhance the removal of recalcitrant PPCPs; (ii) maintenance of high fungal biomass 
concentration improving biodegradation rate; and (iii) effective prevention of enzyme washout. 
Nevertheless, bacterial contamination may hamper the growth and enzymatic activity of whole-cell WRF 
in any reactor configuration. Impacts of bacterial contamination on WRF are discussed in the next 
section.  
3.1.3. Performance under non-sterile environment 
The capacity of WRF for PPCP removal has been commonly investigated under sterile conditions to 
avoid bacterial contamination. Fungal bioreactors have also been operated under non-sterile conditions 
but for a short period of time [24, 26, 58]. Bacterial contamination in the bioreactor adversely affects 
PPCP removal efficiency by: (i) creating competition between bacteria and fungi for substrate; (ii) 
damaging the fungal mycelium; and (iii) disrupting the growth of fungi [26, 70]. Therefore, it is important 
to develop techniques for an uninterrupted growth of fungal strains and to enhance their competitiveness 
over bacteria. Some of the strategies to avoid bacterial contamination are outlined below: 
(i) Operation under acidic pH: Optimum pH for the growth and reproduction of fungi ranges from 
4.5-5. Conversely, bacteria grow at or near neutral pH. Bacterial growth can be suppressed by 
maintaining the pH in the range of 4.5-5. However, this is a temporary solution to the problem of 
bacterial contamination because some bacteria can eventually adapt to acidic environment [74].  
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(ii) Immobilization or attached growth of fungi: Immobilization of fungal strains onto different 
carriers under non-sterile conditions shows promising results. For instance, by immobilizing C. 
versicolor onto a plastic support, Hai et al. [72] was able to prevent bacterial contamination for an 
extended period of time while operating the reactor under non-sterile conditions for the treatment 
of an azo dye. 
(iii) Nitrogen limited feed: Bacterial contamination can be avoided by using a media deficient of 
nitrogen. However, this strategy can only help during the startup of the bioreactor. Bacterial 
contamination would occur with the passage of operating time as bacteria would start consuming 
carbon and nitrogen available in fungal mycelium [74].    
(iv) Coupling of bioreactor with micro-screen: Bioreactors can be coupled with a micro-screen which 
would retain fungal biomass but allow the washout of bacteria with effluent. Moreover, this 
strategy will benefit from using shorter hydraulic retention times, which will enhance the washout 
of bacteria from the reactor [75].  
(v) Use of disinfecting agents: Inactivation of bacteria without imposing any harmful effects on 
fungal biomass can be a promising strategy. Depending on the wastewater characteristics, it is 
important to carefully select the type, dose and contact time of the disinfectant. Disinfection of 
wastewater using ozone has been used successfully to selectively inactivate bacteria [76, 77].  
(vi) Biomass replacement: Periodic biomass replacement and purging strategy can be used to carry 
out long term operation of fungal bioreactors. In this strategy, biomass in the bioreactor is purged 
and renewed in different fractions (e.g., ½ or ¼th of the initial biomass volume) at different 
frequencies [78, 79].   
(vii) Pretreatment of wastewater: Coagulation-flocculation pretreatment of non-sterile wastewater can 
help to reduce the initial bacterial count which would allow an extended operation of the fungal 
bioreactor [79].  
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3.2. Removal by Extracellular LME  
Individual extracellular LME have been tested for the removal of a wide range of pollutants. Use of the 
harvested enzyme instead of a whole-cell preparation allows decoupling of fungal growth and pollutant 
degradation steps and this can be a suitable strategy to avoid bacterial contamination issues. The capacity 
of both crude and purified/commercially available extracellular LME for PPCP removal has been reported 
previously [27, 41, 42, 80, 81, 82, 83, 84, 85, 86]. However, whole-cell fungi may achieve relatively 
better removal of a broader spectrum of pollutants than extracellular LME due to the availability of 
extracellular, intercellular and/or mycelium bound enzymes in addition to sorption of pollutants onto 
fungal biomass. In this section the performance of crude, purified or commercially available extracellular 
enzymes are discussed.  
3.2.1. Performance of Crude LMEs 
Crude extracellular enzymes have been investigated for the degradation of PPCPs in both batch and 
continuous mode. For instance, Wen et al. [87] achieved significant degradation of two pharmaceuticals, 
oxytetracycline (84%) and tetracycline (72%), by using crude MnP (40 U/L) extracted from P. 
chrysosporium. Similarly, crude enzyme solution extracted from T. versicolor containing MnP (30 U/L) 
and laccase (1500 U/L) was tested for the degradation of 10 pharmaceuticals at an initial concentration of 
10 µg/L each [80]. They achieved complete degradation of five pharmaceuticals diclofenac, ibuprofen, 
naproxen, indomethacin and fenoprofen, while the rest were partially removed. LiP extracted  from P. 
chrysosporium was tested for the degradation of diclofenac and carbamazepine at different pH [88]. It 
was observed that degradation of carbamazepine was mostly <10%, whereas a complete degradation was 
achieved for diclofenac at pH 3-4.5. Similarly, crude extract from T. versicolor was used for the removal 
of 30 TrOCs including PPCPs [81]. The results revealed that all steroid hormones were almost completely 
removed (>95%), while removal of two PPCPs namely diclofenac and triclosan ranged from 50-60% with 
poor removal of the remaining PPCPs (<20%). In another study [89], crude enzyme extract from P. 
ostreatus achieved low removal (<20 %) for two PPCPs, namely, oxybenzone and naproxen. Since WRF 
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also secretes natural mediators along with LMEs, crude enzyme may achieve better PPCP removal 
efficiency compared to purified and/or commercially available LME. For instance, Tran et al. [80] 
highlighted that complete removal (>99%) of some pharmaceuticals such as diclofenac, indomethacin and 
ibuprofen was due to the presence of some natural mediators in crude laccase solution.  
Removal performance of selected PPCPs by individual crude enzymes has been systematically presented 
in Table 2. It can be seen that the extent of PPCP removal is different for each type of LME. Moreover, 
crude enzyme extract from different fungi may perform differently. For instance, Weng et al. [90] 
collected crude LiP from two WRF species, namely, P. sordida and P. chrysosporium for the treatment of 
EDCs and found that LiP from P. sordida was more effective than LiP from P. chrysosporium. Similarly, 
removal of DEET, an insect repellent, by T. versicolor was 55% in real wastewater compared to its 20% 
removal in acetate buffer. High removal of DEET in real wastewater was attributed to the presence of 
other compounds (such as phenolic compounds) which may act as redox-mediators [91], as further 
discussed in a following section.  
[TABLE 2] 
3.2.2. Performance of Purified LME 
Purified LME, mostly laccase from different WRF, has been used for the treatment of PPCPs in both 
batch and continuous reactors. Average removal of PPCPs by purified laccase reported in recent studies is 
presented in Figure 1. Purified laccases are more effective for the removal of phenolic compounds such as 
oxybenzone, triclosan and steroid hormones. Removal of non-phenolic compounds such as 
carbamazepine, naproxen and ketoprofen is generally poor/unstable. Their degradation depends on their 
physicochemical properties such as hydrophobicity and chemical structure as well as the oxidation 
reduction potential (ORP) of the enzyme [31, 102]. Indeed, based on the results of the recent studies 
incorporated in Figure 1, removal of phenolic compounds ranges from 70-99%, while the removal of non-
phenolics is generally <20%. However, relatively higher removal of some non-phenolic compounds, 
namely, diclofenac (40-50%), octocrylene (>80%) and ibuprofen (30-45%) has been reported because 
12 
 
these compounds contain both electron donating and electron withdrawing functional groups. Although 
both crude and purified LMEs demonstrated degradation of a range of pollutants, crude LMEs achieved 
better removal of some PPCPs such as diclofenac and naproxen compared to purified LMEs [27, 41, 81, 
82, 83, 85], possibly due to the presence of natural mediators in crude LMEs secreted by WRF. For 
instance, Tran et al. [80] achieved almost complete removal of three pharmaceuticals namely diclofenac, 
ibuprofen and naproxen after treatment with crude enzyme extracted from T. versicolor, whereas purified 
laccase from T. versicolor and A. oryzae achieved 20-50% removal of these compounds [82, 83, 84, 103]. 
Additionally, utilization of crude LMEs for the treatment of PPCPs may considerably reduce the cost of 
the treatment process. However, extracellular extract i.e., the crude enzyme solution also contains 
significant amount of the unspent growth media, and dosing crude enzyme means additional organic 
loading from this. 
[FIGURE 1] 
3.3. Performance of Redox-mediator Enhanced Laccase Catalyzed System 
Laccase catalyzes mono-electronic oxidation of PPCPs. However, the extent of removal depends on the 
ORP of the enzyme and individual PPCP. Poor removal of non-phenolic PPCPs can be attributed to: (i) 
presence of a strong EWG in the structure of non-phenolic compounds causing steric hindrance; and (ii) 
higher ORP of non-phenolic compounds than laccase [102]. Removal of non-phenolic compounds can be 
enhanced by introducing a low-molecular weight redox-mediator. In a redox-mediator catalyzed system, 
highly reactive radicals are formed due to the oxidation of a mediator by laccase and these radicals then 
serve as an electron transfer shuttle between PPCPs and laccase, facilitating enhanced removal of 
recalcitrant compounds. Three oxidation mechanisms, namely hydrogen atom transfer (HAT), ionic 
mechanisms and electron transfer have been reported for mediators. For instance, 1-hydroxybenzotriazole 
(HBT) and syringaldehyde (SA) follow HAT mechanism, while 2,2-azino-bis(3-ethylbenzothiazoline-6-
sulfnoic acid (ABTS) and 2,2,6,6-tetramethylpiperidinyloxyl (TEMPO) follow electron transfer and ionic 
mechanisms, respectively [89, 109]. 
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Properties of different redox-mediators used to enhance the removal of different PPCPs are summarized 
in Table 3. Although the mediators perform differently, two mediators namely HBT and SA have been 
commonly used to broaden the spectrum of compounds significantly degraded by laccase. Studies 
involving these mediators confirmed that they not only improved the ORP of reaction mixture but also the 
extent of removal. Only a few studies elucidated the performance of different mediators based on the type 
of substrate (i.e., phenolic vs. non-phenolic). For instance, N-OH type mediators (VA and HBT) were 
found to achieve the best removal of non-phenolic PPCPs such as clofibric acid, naproxen and 
carbamazepine, whereas SA and ABTS performed  better for phenolic compounds such as salicylic acid 
and steroid hormones [82, 83, 85]. 
Mediator type, concentration and compound properties influence the performance of a mediator catalyzed 
system. For instance, removal of diclofenac improved from 40 to 80% by increasing the concentration of 
SA from 0.1 to 0.5 mM [103]. Similarly, Nguyen et al. [85] achieved an improvement of 35% in the 
removal of diclofenac in an enzymatic membrane reactor by increasing the dose of SA from 0.01 mM to 
0.1 mM. However, beyond a threshold concentration increasing mediator dose may not improve the 
removal of PPCPs. For instance, Ashe et al. [89] observed that increasing the concentration of VA and 
ABTS from 0.5 to 1 mM could not enhance the removal of oxybenzone and naproxen. They also 
observed that removal of atrazine was reduced by 15-25 % when the concentration of VA and HBT was 
increased from 0.1 to 0.25 mM. This may be attributed to the complex interactions between laccase and 
the radicals generated due to degradation of the mediator by laccase, as discussed below. 
[TABLE 3] 
It has been observed in almost all the studies that enzymatic activity significantly drops with the addition 
of mediators. For instance, Hata et al. [111] observed 90% decline in enzymatic activity within fist 8 h of 
incubation in the presence of HBT. Similarly, rapid decline in enzymatic activity was also observed with 
the addition of VA, HBT or ABTS [89], although rate of enzyme inactivation depends on the relative 
stability of the radicals generated by mediators. In the absence of any known enzyme inhibitor, rapid 
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enzyme inactivation in mediator catalyzed system can be attributed to: (i) the blockage of active sites of 
the enzyme by charged radicals and metabolites; and (ii) the reaction of metabolites with enzyme-active 
sites to convert them into non-productive complexes [112, 113].  
Despite rapid inactivation of enzymes by different mediators, mediators can compensate by enhancing the 
rate of reaction, eventually achieving rapid and enhanced removal of PPCPs. However, periodic 
replenishment of enzyme is needed to maintain the removal efficiency of PPCPs, constraining the long 
term operation of mediator-enzyme based wastewater treatment processes. Therefore, selection of 
mediator type and its concentration is vital for effective and long term operation of such systems.  
4. Impacts of Physicochemical Characteristics of Wastewater   
Performance of WRF in wastewater treatment depends on a number of factors such as environmental 
conditions and physiochemical properties of the wastewater as well as the properties of PPCPs. Influence 
of PPCP properties on their overall removal in a WRF mediated treatment process has been reviewed by 
Yang et al. [31]. Briefly, physicochemical properties of water/wastewater such as pH, temperature and the 
presence of dissolved organic and/or inorganic compounds may influence WRF performance. Because 
information about these properties are vital to design and optimize WRF mediated treatment systems, 
these are discussed in this section.  
The operating temperature not only affects the stability of WRF enzymatic systems but also the rate of 
reaction. It is believed that the rate of reaction increases with  increase in temperature [88]. However, 
depending on the WRF strain, rapid thermal inactivation of LMEs has been observed at temperature 
>40
o
C [114, 115]. Only a few studies have investigated the impact of temperature on LME activity and 
removal efficiency in a reaction mixture. For instance, increase in temperature of the reaction mixture 
from 20 to 25oC enhanced the removal efficiency of chlorophenols in laccase mediated treatment [116]. 
Similarly, Ullah et al. [117] investigated the removal of pentachlorophenol by varying the temperature 
from 10-45
 o
C and found that the optimal temperature was 25
o
C to achieve maximum laccase activity and 
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pentachlorophenol removal. Temperature range of 37-40
 o
C has been reported to achieve optimal activity 
of MnP and LiP [87, 118].  
Enzyme performance and substrate properties can be influenced by pH of the reaction mixture, thereby 
affecting the extent of PPCP removal. For instance, optimum pH for the removal of diclofenac (60-100%) 
by purified laccase (T. versicolor and M. thermophile) and LiP (P. chrysosporium) was in the range of 3.0 
– 4.5 [83, 88, 103, 105]. Similarly, Wen et al. [87] observed that the removal of two antibiotics, namely 
tetracycline and oxytetracycline, by crude LiP and MnP was pH dependent and the best removal was 
achieved at pH 4.5-5.0. However, optimum pH for the removal of a personal care product triclosan was in 
the range of 5-5.5 during the treatment with laccase from T. versicolor [93, 116]. Media pH may not 
affect the removal of compounds highly amenable to laccase-catalyzed degradation. For instance, laccase 
from T. versicolor achieved significant removal (>70%) of steroid hormones over a pH range of 4 - 7 
[103]. Similarly, changing the pH from 2.5- 6 could not improve the removal of carbamazepine by LiP 
[88]. In light of the above discussion, pH ranging from 4-5-5 is recommended for WRF mediated 
treatment processes.  
The impact of dissolved organic and inorganic constituents on laccase activity and PPCP removal has 
been communicated in a limited number of studies. Many compounds such as sulphides, halides [119, 
120], natural/synthetic organics [121, 122, 123, 124, 125, 126] and heavy metals [92, 127] can inhibit the 
catalytic activity of laccases [128]. Moreover, each compound may have different mode of laccase 
inhibition. For instance, fatty acids inhibit laccase catalytic potential by blocking the binding sites for 
phenolic substrates [129, 130, 131]. On the other hand, spectrophotometric assays, electron spin 
resonance spectroscopy and catalytic voltammetry analysis confirmed that anionic inhibitors such as 
halides and sulphides could block the access to the active copper sites in laccase [132, 133, 134]. Among 
anionic inhibitors, fluoride and azide are the most effective and can rapidly reduce the catalytic activity of 
laccase by 50% even at µM concentrations [135]. Although inhibition of laccases by halides can proceed 
in the following order: fluoride > chloride > bromide, the concentration of halides required to inhibit 
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laccases varies, with no fixed correlation with their inhibition potential. For instance, chloride 
concentration ranging from 100 µM – 100 mM may cause a 50% drop in activity of laccase from different 
species [35, 136].  
5. Removal Mechanisms  
Removal mechanisms during treatment with WRF whole-culture include (i) sorption onto the fungal 
biomass; (ii) degradation by extracellular enzymes; and (iii) degradation by mycelium bound or 
intercellular enzymes. A schematic of fungal mediated treatment process with possible removal 
mechanisms is presented as Figure 2. Hydrophobicity (log D) of PPCPs is a key property that governs 
biosorption onto fungal biomass and could facilitate enhanced removal of some compounds. For instance, 
a batch study to investigate the contribution of biosorption and degradation by extracellular enzymes 
confirmed that hydrophobic PPCPs (log D>4) were highly removed by both mechanisms [41]. Moreover 
this study also confirmed that biosorption of significantly hydrophobic compounds facilitated the 
biodegradation of these compounds. On the other hand, a few studies have reported that removal of some 
PPCPs such as 17β-Estradiol, 17α-Ethynylestradiol, triclosan and nonylphenol by whole-cell WRF and 
extracellular enzymes is comparable (see Table 1 and 2), indicating a negligible impact of biosorption on 
their removal.  
Biodegradation by whole-cell can be due to intracellular, extracellular and mycelium-associated enzymes. 
This can lead to significant differences in removal by whole-cell WRF and harvested enzyme. For 
instance, carbamazepine, containing a strong EWG, was significantly removed by some WRF species 
namely P. ostreatus (100%) [45] and T. versicolor ATCC 42530 (76%) [80], whereas crude [45, 80, 81] 
and purified laccase [82, 85] could only achieve 5-15% carbamazepine removal. Similarly, ibuprofen and 
naproxen were almost completely removed by whole-cell WRF [24, 43, 58]. In contrast, their removal by 
crude and purified laccase was in the range of 10-40% [27, 82, 85, 103]. Since both naproxen and 
ibuprofen are hydrophilic compounds (log D <3), role of biosorption in their removal would be limited. 
However, almost complete removal of these compounds in whole-cell WRF substantiates the role of 
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mycelium bound and/or or intercellular enzymes. Indeed, the role of intercellular enzyme (i.e. cytochrome 
P450) in the degradation of naproxen, diclofenac and carbamazepine has been demonstrated [43, 45, 137]. 
These studies showed that naproxen, diclofenac and carbamazepine were partially removal (15-50%) in 
the presence of cytochrome P450 inhibitor during whole-cell WRF treatment. Therefore, it can be 
concluded that high removal of some PPCPs in whole-cell WRF treatment is due to the synergetic effects 
of extracellular, intercellular and/or mycelium bound enzymes. Moreover, secretion of natural mediators 
may also help in enhancing the removal of these compounds.    
 [FIGURE 2] 
6. Degradation Pathways and Identification of Intermediates  
PPCP degradation pathways and their intermediate products have been identified for some compounds 
such as carbamazepine, diclofenac, triclosan and ibuprofen. However, each WRF species may follow a 
different degradation pathway. Degradation pathways and intermediate products of some PPCPs are 
discussed in this section.  
Fungal mediated treatment of diclofenac starts with the conversion of the hydroxyl group in its structure 
into an intermediate product, namely, hydroxy diclofenac. Hydroxy diclofenac can be amenable to further 
fungal biodegradation [137, 138]. In vivo and in vitro experiments for the degradation of diclofenac 
showed that laccase (T. versicolor) catalyzed degradation leads to the formation of biodegradable 
compounds such as: (i) hydroxelated metabolites (appeared in both in vivo and in vitro experiments); and 
(ii) 4-(2,6 dichlorophenylamino)-1,3-benzenedimethanol metabolite (appeared only in in vivo 
experiments) [138]. Diclofenac and its metabolites both disappeared after 24 h of incubation, reducing the 
ecotoxicity of the treated effluent. Degradation of ketoprofen was reported to initiate by the intercellular 
cytochrome P450 that converts ketoprofen into (2-[3-(4-hydroxybenzoyl)phenyl]-propanoic acid) and (2-
[(3-hydroxy(phenyl)-methyl)phenyl]-propanoic acid) via hydroxylation and reduction of the ketone 
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group, respectively [138]. Moreover, it was also observed that the role of extracellular enzyme (laccase) 
in the degradation of ketoprofen was insignificant.  
Both laccase and cytochrome P450 can catalyze the degradation of naproxen in WRF based treatment. 
Formation of two intermediates, namely 6-desmethylnaproxen and 1-(6-methoxynaphthalen-2-
yl)ethanone), was observed possibly via P450-mediated desmethylation and laccase catalysis, respectively 
[43, 57]. Moreover, naproxen and associated intermediates were completely removed from the reaction 
mixture and the treated effluent was non-toxic [43].  
Ibuprofen conversion predominantly starts with the formation of hydroxy-ibuprofen via hydroxylation. 
Marco-Urrea et al. [139] investigated the degradation pathways of ibuprofen by WRF T. versicolor. They 
observed that oxidation of isopropyl chain resulted in the formation of 1-hydroxy ibuprofen and 2-
hydroxy ibuprofen. These intermediates were then degraded by T. versicolor to 1,2-dihydroxy ibuprofen, 
which was not further degraded. Hence, the ecotoxicity of treated effluent was higher than that of the 
initial solution [139]. 
Degradation pathways for carbamazepine by different whole-cell WRF including T. versicolor and P. 
ostreatus have also been studied. These have identified a number of stable intermediate products namely, 
10,11-dihydro-10,11-dihydroxy-carbamazepine, acridine, acridone and 10,11-epoxy-carbamazepine. 
Interestingly, the treated effluent showed less toxicity [45, 53].  
Intermediates or metabolites of triclosan during whole-cell treatment depends on WRF species. Major 
intermediates of triclosan during the treatment with C. polyzona WRF were dimer, trimer and tetramer 
[140], while 2-O-(2,4,4-trichlorodiphenyl ether)-b-D-xylopyranoside, 2-O-(2,4,4-trichlorodiphenyl ether)-
b-D-glucopyranoside and 2,4-dichlorophenol were identified as major intermediates following its 
treatment with T. versicolor [141]. 
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7. Future Scope of Research       
Performance of whole-cell WRF has mostly been investigated in sterile batch tests. Only a few studies 
have been conducted in continuous flow reactors under non-sterile conditions [24, 26, 27, 58], because 
bacterial contamination can seriously affect WRF performance. Therefore, more efforts are required to 
solve this limitation.  
Another limitation of WRF mediated treatment process is the washout of the enzyme and mediators with 
treated effluent. This is particularly problematic for enzymatic reactors where enzymes instead of whole-
cell WRFs are used. Enzyme immobilization or coupling of enzymatic reactor with a membrane with 
suitable pore size can be used to avoid enzyme washout [27, 82, 83, 85, 142, 143]. Coupling of membrane 
separation with an enzymatic reactor offers several advantages over immobilized enzymatic systems such 
as: (i) more effective enzyme retention; (ii) reduced mass transfer limitations; (iii) ease of enzyme 
replenishment and (iv) ease of operation and maintenance [29, 144]. Moreover, enhanced TrOC removal 
by enzymatic membrane bioreactors (EMBR) has been demonstrated in a few recent studies [82, 83]. 
While investigating the removal of 30 TrOCs in an EMBR, Nguyen et al. [82] observed retention of 
PPCPs such as gemfibrozil, naproxen and ketoprofen on the enzyme gel layer formed over the membrane. 
It was also confirmed that the compounds retained by the enzyme gel layer were subsequently 
biodegraded [82]. Despite enhanced removal of some PPCPs, EMBR may not be effective to protect 
enzymes from thermal and chemical denaturation. In such situations, immobilized enzymatic systems 
have been reported to be more effective than free enzymes [145, 146, 147]. In enzyme-mediator systems, 
redox-mediators may still pass through the membrane with the treated effluent, thus increasing the 
operating costs. Washout of redox-mediators can be prevented by integrating a high retention membrane 
such as nanofiltration, membrane distillation or forward osmosis membrane with the enzymatic reactor, or 
formulating strategies to recover mediators from effluent.  
Degradation pathways of only a few PPCPs such as carbamazepine, diclofenac, ibuprofen and naproxen 
have been reported in literature. The intermediate products in some cases are more toxic than the parent 
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compound. Therefore, more efforts are required to identify and elucidate the formation of intermediate 
products during WRF mediated treatment of PPCPs which would help to further understand the 
degradation mechanisms of PPCPs.  
8. Conclusion 
WRF mediated treatment of PPCPs is a promising and environmentally friendly technology. Varieties of 
PPCPs are efficiently removed by both whole-cell WRF and crude/purified LMEs. Hydrophilic and 
persistent PPCPs such as naproxen, ketoprofen and carbamazepine are significantly removed only in 
whole-cell WRF treatment because of the synergistic effects of extracellular and intercellular enzymes as 
well as sorption onto fungal biomass. Different redox-mediators have been introduced to enhance the 
removal of persistent PPCPs but continuous addition of mediators is an expensive practice. Therefore, 
mediator type and concentration must be selected carefully and techniques to recover mediators be 
optimized. Operating conditions of the enzymatic reactor including pH, temperature and interfering 
dissolved contaminants could influence the performance of WRF mediated treatment process. Despite the 
better performance of whole-cell WRF treatment than crude and purified enzymes, long term continuous 
operation of fungal bioreactor could not be possible due to bacterial contamination. This problems needs 
to be solved before their full scale applications.   
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Table 1: Removal (%) of PPCPs by different species of WRF (whole-cell) under different operating conditions  









Stirred tank  Inoculum= 1.2 g/L  Diclofenac  0.8 >99 
[56] 
(Batch-fed) Reactor volume = 2 L, HRT= 24 h Ibuprofen 0.8 75-99 
 Mixing speed = 200 rpm Naproxen  0.8 >99 
 pH = 4.5; Temperature= 30
o
C    
 Electron donor= glucose     
 Operating time= 30 days    
Stirred tank  Reactor volume = 1.5 L Diclofenac  1 92 
[57] 
(Continuous)  HRT= 24 h Ibuprofen 1 95 
 pH = 4.5; Temperature= 30
o
C Naproxen  1 95 
 Electron donor= glucose  Carbamazepine  0.5 25-60 
 Operating time= 50 days Diazepam 0.25-0.5 0 
T. versicolor 
(Laccase, LiP, MnP) 
Fixed bed Inoculum= 3.2 g/L    
[51] 
(Continuous) Reactor volume = 0.13 L 17β-estradiol (E1) 3-18.8 >95 




 pH = 4.5; Temperature= 22
o
C    
 Electron donor= glucose    
 Operating time= 26 days    
Fluidized bed Inoculum= 3.8 g Carbamazepine 0.05-9 61-94 
[53] 
(Batch-fed) Reactor volume = 1.5 L    
 pH = 4.5; Temperature= 25oC    
 Electron donor= glucose    
 Operating time= 15 days    
Fluidized bed Inoculum= 1.5 g/L Ibuprofen 2.34 100 
[24] 
(Batch-fed) Reactor volume = 10 L Acetaminophen 1.56 100 
 pH = 4.5; Temperature= 25
o
C Ketoprofen 0.08 100 
 Electron donor= glucose Ciprofloxacine 84.71 35 
 Operating time= 8 days Azithromycin 4.31 100 
 Real hospital wastewater  Propranolol 0.06 100 
 Non sterile conditions Carbamazepine 0 -50 
Fluidized bed Inoculum= 1.4 g/L Acetaminophen 109 100 [58] 
31 
 
(Continuous) Reactor volume = 10 L Naproxen 1.62 100 
 pH = 4.5; Temperature= 25
o
C Ibuprofen 35.5 100 
 Electron donor= glucose Ketoprofen 2.17 95 
 Operating time= 8 days Diclofenac 0.477 100 
 Real hospital wastewater  Codeine 0.606 100 
 Non sterile conditions Phenazone 0.497 96 
  Salicylic Acid 0.606 0 
  Ofloxacin 3.34 98 
  Ciprofloxacine 13.0 99 
  Sulfamethoxazole 1.41 100 
  Trimethoprim 0.853 100 
  Metronidazole 0.912 85 
  Azithromycin 1.37 26 
  Clarithromycin 2.20 80 
  Erithromycin 0.008 100 
  Tetracyclin 0.011 0 
  Caffeine 149 39 
  Carbamazepine 0.056 0 
  Atenolol 2.99 75 
  Metoprolol 0.019 95 
Membrane 
bioreactor 
Inoculum= 3.5 g/L Diclofenac  
0.3-1.5 55 
[26] 




 pH = 5.4; Temperature= 27
o
C    
 Operating time= 90 days    
 Non sterile conditions    
Membrane 
bioreactor 
Inoculum= 3 g/L Ibuprofen 
0.005 95 
[27] 




 pH = 4.5; Temperature= 27
o
C Ketoprofen 0.005 90 
 Operating time= 110 days Diclofenac  0.005 50 
 Non sterile conditions Carbamazepine 0.005 20 
  Metronidazole 0.005 40 
  Gemfibrozil 0.005 95 
  Amitriptyline 0.005 85 
  Estriol (E3) 0.005 >95 
  17-β-estradiol 0.005 >95 
32 
 
  17-β-estradiol –
acetate 
0.005 >95 
  17-α 
ethinylestradiol 
0.005 >95 
  Triclosan 0.005 95 
  Benzophenone 0.005 80 
  Oxybenzone 0.005 92 
  Octocrylene 0.005 94 
Erlenmeyer 
flask 
Inoculum= 2-3 mg/test Triclosan 
10 98 
[52] 





 Operating time= 14 days Nonylphenol  10 90 





Inoculum= 2-3 mg Triclosan 
10 98 
[52] 





 Operating time= 14 days Nonylphenol 10 93 





Inoculum= 2-3 mg Triclosan 
10 98 





 Operating time= 14 days Nonylphenol  10 85 
B. adusta 
(Laccase, LiP, MnP) 
Erlenmeyer 
flask 
Inoculum= 2-3 mg Triclosan 
10 98 












Table 2: Performance of crude LME for the removal (%) of PPCPs  
PPCPs Laccase
 [80, 81, 89, 91, 92, 93, 94, 95, 96, 97, 98, 99]
 LiP
 [88, 90, 100]
 MnP
























Carbamazepine  5 – 37 0.01-0.1 24-48 <10 5 2 14-20 0.01-4.7 24-48 
Ibuprofen <5 – 38 0.01-0.1 24-48 - - - 20 0.01 48 
Naproxen 20-100 0.01-0.5 24-48 - - - 95 0.01 48 
Diclofenac   60-100 0.01-0.1 3-48 >99 5 2 100 0.01 48 
Gemfibrozil  20-25 0.01-0.1 24-48 - - - 30 0.01 48 
ketoprofen  <5 -12 0.01-0.1 24-48 - - - 22 0.01 48 
Clofebric acid  10-20 0.01-0.1 24-48 - - - <10 0.01 48 
Benzophenone  <5 0.1 24 - - - - - - 
DEET 20-55 0.01 4 - - - - - - 
Octocrylene  20 0.1 24 - - - - - - 
Phenolic compounds          
Estrone 70-100 0.1-27 1-24 60 27 24 >99 5 8 
17β-Estradiol >99 0.01-5 1-24 40, 85 0.6, 27 1, 24 >99 2.96 1 
17α-Ethynylestradiol >99 0.1-2.96 1-24 20, 82 6.6, 30 8, 24 >99 2.96 1 
Oxybenzone  10-25 0.1-0.5 24 - - - - - - 
Nonylphenol 100 22 1 - - - - - - 
Triclosan 70-90 0.1-144 24 - - - - - - 






Table 3: Properties of redox-mediators used to improve the performance of laccase based treatment of PPCPs 
Redox-mediator  Type of mediator Free radicals 
Oxidation 
mechanism 
Application for TrOC 
removal 
References 
1-hydroxibenzotriazole (HBT) N-OH/ synthetic aminoxyl 
Hydrogen atom 
transfer 
PPCPs, EDCs, pesticides 
and industrial chemicals 
[43, 81, 89, 104, 
105, 110] 
Violuric acid (VA) N-OH/ natural aminoxyl 
Hydrogen atom 
transfer 
PPCPs, pesticides and 
industrial chemicals 
[89, 90] 
N-hydroxyphthalimide (HPI) N-OH/ synthetic aminoxyl 
Hydrogen atom 
transfer 
PPCPs and pesticides  [89] 






PPCPs, EDCs, pesticides 
and industrial chemicals 








PPCPs, EDCs, pesticides 
and industrial chemicals 
[89, 90, 110] 
2,2,6,6-tetramethylpiperidinyloxyl (TEMPO) N – O / synthetic Oxoammonium Ionic  
PPCPs, EDCs, pesticides 
and industrial chemicals 
[89, 90, 110] 
2,2-azino-nis(3-ethylbenzothiazoline-6-







PPCPs, EDCs, pesticides 









































































































































































































































































































 Non-phenolic PPCPs  
Figure 1. Average removal of phenolic and non-phenolic PPCPs after treatment with 
purified/commercially available laccase. Error bar indicates average±standard deviation. Numbers within 
parenthesis indicates number of data points. Data was collected from the following studies: [82, 83, 84, 






Figure 2. A schematic representation of whole-cell WRF mediated treatment process    
 
